Climate Change and Infectious Diseases
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Climate Change and Human Health: Risks and Responses
Climate change and human health RISKS AND RESPONSES Editors A.J. McMichael The Australian National University, Canberra, Australia D.H. Campbell-Lendrum London School of Hygiene and Tropical Medicine, London, United Kingdom C.F. Corvalán World Health Organization, Geneva, Switzerland K.L. Ebi World Health Organization Regional Office for Europe, European Centre for Environment and Health, Rome, Italy A.K. Githeko Kenya Medical Research Institute, Kisumu, Kenya J.D. Scheraga US Environmental Protection Agency, Washington, DC, USA A. Woodward University of Otago, Wellington, New Zealand WORLD HEALTH ORGANIZATION GENEVA 2003 WHO Library Cataloguing-in-Publication Data Climate change and human health : risks and responses / editors : A. J. McMichael . [et al.] 1.Climate 2.Greenhouse effect 3.Natural disasters 4.Disease transmission 5.Ultraviolet rays—adverse effects 6.Risk assessment I.McMichael, Anthony J. ISBN 92 4 156248 X (NLM classification: WA 30) ©World Health Organization 2003 All rights reserved. Publications of the World Health Organization can be obtained from Marketing and Dis- semination, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: [email protected]). Requests for permission to reproduce or translate WHO publications—whether for sale or for noncommercial distribution—should be addressed to Publications, at the above address (fax: +41 22 791 4806; email: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. -
Substantial Vegetation Response to Early Jurassic Global Warming with Impacts on Oceanic Anoxia
ARTICLES https://doi.org/10.1038/s41561-019-0349-z Substantial vegetation response to Early Jurassic global warming with impacts on oceanic anoxia Sam M. Slater 1*, Richard J. Twitchett2, Silvia Danise3 and Vivi Vajda 1 Rapid global warming and oceanic oxygen deficiency during the Early Jurassic Toarcian Oceanic Anoxic Event at around 183 Ma is associated with a major turnover of marine biota linked to volcanic activity. The impact of the event on land-based eco- systems and the processes that led to oceanic anoxia remain poorly understood. Here we present analyses of spore–pollen assemblages from Pliensbachian–Toarcian rock samples that record marked changes on land during the Toarcian Oceanic Anoxic Event. Vegetation shifted from a high-diversity mixture of conifers, seed ferns, wet-adapted ferns and lycophytes to a low-diversity assemblage dominated by cheirolepid conifers, cycads and Cerebropollenites-producers, which were able to sur- vive in warm, drought-like conditions. Despite the rapid recovery of floras after Toarcian global warming, the overall community composition remained notably different after the event. In shelf seas, eutrophication continued throughout the Toarcian event. This is reflected in the overwhelming dominance of algae, which contributed to reduced oxygen conditions and to a marked decline in dinoflagellates. The substantial initial vegetation response across the Pliensbachian/Toarcian boundary compared with the relatively minor marine response highlights that the impacts of the early stages of volcanogenic -
Causes of Sea Level Rise
FACT SHEET Causes of Sea OUR COASTAL COMMUNITIES AT RISK Level Rise What the Science Tells Us HIGHLIGHTS From the rocky shoreline of Maine to the busy trading port of New Orleans, from Roughly a third of the nation’s population historic Golden Gate Park in San Francisco to the golden sands of Miami Beach, lives in coastal counties. Several million our coasts are an integral part of American life. Where the sea meets land sit some of our most densely populated cities, most popular tourist destinations, bountiful of those live at elevations that could be fisheries, unique natural landscapes, strategic military bases, financial centers, and flooded by rising seas this century, scientific beaches and boardwalks where memories are created. Yet many of these iconic projections show. These cities and towns— places face a growing risk from sea level rise. home to tourist destinations, fisheries, Global sea level is rising—and at an accelerating rate—largely in response to natural landscapes, military bases, financial global warming. The global average rise has been about eight inches since the centers, and beaches and boardwalks— Industrial Revolution. However, many U.S. cities have seen much higher increases in sea level (NOAA 2012a; NOAA 2012b). Portions of the East and Gulf coasts face a growing risk from sea level rise. have faced some of the world’s fastest rates of sea level rise (NOAA 2012b). These trends have contributed to loss of life, billions of dollars in damage to coastal The choices we make today are critical property and infrastructure, massive taxpayer funding for recovery and rebuild- to protecting coastal communities. -
Sars-Cov-2 Infection in Healthcare Workers and Their Household Contacts at the University of North Carolina Medical Center
VECTOR OR VICTIM: SARS-COV-2 INFECTION IN HEALTHCARE WORKERS AND THEIR HOUSEHOLD CONTACTS AT THE UNIVERSITY OF NORTH CAROLINA MEDICAL CENTER Team Co-PIs: Ross Boyce, MD (SOM) and Allison Aiello, PhD (SPH) Coinvestigators: David Richardson, PhD (SPH), David Weber, MD (SOM), Emily Sickbert-Bennett, PhD, MS (SOM), Erica Pettigrew Md, JD, MPH (SOM), Raquel Reyes, MD (Hospital Medicine), Naseem Alavian, MD (Hospital Medicine), Jon Juliano, MD, MPH (SOM) Emily Ciccone MD,MHS (SOM), Billy Fischer, MD (SOM) and Subha Sellers, MD,MSc (SOM) The COVID-19 pandemic now accounts for more than 1.1 million confirmed infections and nearly than 70,000 deaths in the United States (US), along with unprecedented disruption to social networks and economic systems. The causative agent, the SARS-CoV-2 coronavirus, is primarily spread from person-to-person through the inhalation or direct contact with aerosolized droplets. Frontline healthcare workers (HCW) are at increased risk of infection due to frequent exposure to and close contact with infected patients and contaminated surfaces. Shortages of critical personal protective equipment (PPE) may further exacerbate this risk. A review of the epidemiological data from the site of the initial COVID-19 outbreak in Wuhan, China showed that 63% of HCWs were infected with SARS- CoV-2, many of who developed severe disease. While data from US facilities is still emerging, an analysis of case reports submitted to the Centers for Disease Control and Prevention (CDC) found nearly 10,000 cases of COVID-19 among HCWs. Infected HCWs can also contribute to disease transmission, both in the hospital setting and in the community. -
Chapter 1 Ozone and Climate
1 Ozone and Climate: A Review of Interconnections Coordinating Lead Authors John Pyle (UK), Theodore Shepherd (Canada) Lead Authors Gregory Bodeker (New Zealand), Pablo Canziani (Argentina), Martin Dameris (Germany), Piers Forster (UK), Aleksandr Gruzdev (Russia), Rolf Müller (Germany), Nzioka John Muthama (Kenya), Giovanni Pitari (Italy), William Randel (USA) Contributing Authors Vitali Fioletov (Canada), Jens-Uwe Grooß (Germany), Stephen Montzka (USA), Paul Newman (USA), Larry Thomason (USA), Guus Velders (The Netherlands) Review Editors Mack McFarland (USA) IPCC Boek (dik).indb 83 15-08-2005 10:52:13 84 IPCC/TEAP Special Report: Safeguarding the Ozone Layer and the Global Climate System Contents EXECUTIVE SUMMARY 85 1.4 Past and future stratospheric ozone changes (attribution and prediction) 110 1.1 Introduction 87 1.4.1 Current understanding of past ozone 1.1.1 Purpose and scope of this chapter 87 changes 110 1.1.2 Ozone in the atmosphere and its role in 1.4.2 The Montreal Protocol, future ozone climate 87 changes and their links to climate 117 1.1.3 Chapter outline 93 1.5 Climate change from ODSs, their substitutes 1.2 Observed changes in the stratosphere 93 and ozone depletion 120 1.2.1 Observed changes in stratospheric ozone 93 1.5.1 Radiative forcing and climate sensitivity 120 1.2.2 Observed changes in ODSs 96 1.5.2 Direct radiative forcing of ODSs and their 1.2.3 Observed changes in stratospheric aerosols, substitutes 121 water vapour, methane and nitrous oxide 96 1.5.3 Indirect radiative forcing of ODSs 123 1.2.4 Observed temperature -
Climate Change and Vector-Borne/Zoonotic Diseases
Climate Change and Vector-Borne/Zoonotic Diseases Kenneth L. Gage Division of Vector-Borne Infectious Diseases National Center for Zoonotic, Vector-Borne and Enteric Diseases Centers for Disease Control and Prevention Vector Disease agents Threshold for Effects of Climatic Factors Biological Activity on Hosts and Vectors* Anopheles Plasmodium sp. 8-10o C mosquitoes • Growth, development and reproduction Triatomine Trypanosoma 20o C – Q10 effects (approximate doubling of bugs cruzi (2-6o C for survival) metabolic rates in poikliothermic organisms with 10oC rise in temperatures) Aedes Dengue virus 6-10o C – Rate of reproduction/Number of mosquitoes generations per season – Example: Anopheles gambiae gonotrophic Ixodes ticks Borrelia 5-8o C cycles significantly shorter in open treeless burdgdorferi, sites (warmer) than forested sites (cooler) Anaplasma • Activity patterns phagocytophilum, – Feeding Babesia microti – Host seeking o – Mate seeking etc. Bulinus and Schistosoma sp. 5 C o • Availability of breeding sites other snails (25+2 C optimal) • Survival – Severe weather events Source: Patz and Olson 2006 – Tolerance limits for vectors and hosts – Food or water availability – Freezing or heat stress Effect of Temperature on Oxygen Consumption * See Gubler et al. 2001 for citations and additional examples Climate Effects on Hosts and Vectors - Distribution and Abundance - • “Weather school” (Andrewartha and Birch 1954) – Changing conditions make areas more or less suitable for survival and reproduction, which affects abundance of different species – Changing conditions often related to climatic variables (temperature, precipitation, humidity, etc.) – Most extreme effects seen for insects and other arthropods • Host or vector populations can increase during favorable conditions and later crash as conditions deteriorate • Many examples with epidemiologic significance – Mosquito vectors • Rift valley fever (arbovirus)(Linthicum et al. -
A National Public Health Framework for the Prevention and Control of Vector-Borne Diseases in Humans
A National Public Health Framework for the Prevention and Control of Vector-Borne Diseases in Humans WWW.CDC.GOV/VECTOR 1 Amblyomma maculatum Publication and Copyright Information Centers for Disease Control and Prevention A National Public Health Framework for the Prevention and Control of Vector-Borne Diseases in Humans Atlanta, Georgia: September 2020 www.cdc.gov/vector Media inquiries: 404-639-3286 (9:00 am–6:00 pm ET); [email protected] Acknowledgement: Layout and graphics provided by CDC’s Creative Services. Cover Clockwise from top right: • Blacklegged tick (Ixodes scapularis), James Gathany photographer • Aedes aegypti mosquito, James Gathany photographer • Illustration of the United States • Oriental rat flea Xenopsylla( cheopsis), James Gathany photographer Accessible Version: www.cdc.gov/ncezid/dvbd/framework.html 2 A NATIONAL PUBLIC HEALTH FRAMEWORK FOR THE PREVENTION AND CONTROL OF VECTOR-BORNE DISEASES IN HUMANS Introduction and Scope Our nation’s ability to defend against the present the U.S. population from these diseases, five federal and future threat of vector-borne diseases relies on a departments and the Environmental Protection Agency comprehensive national system that is able to detect, contributed to developing a national framework for vector- prevent, and respond to these threats. A concerted borne disease prevention and control. These federal and sustained effort is needed to address significant partners represent the primary federal departments and challenges and reverse the upward trends in illness, agencies engaged -
Chapter 2 Disease and Disease Transmission
DISEASE AND DISEASE TRANSMISSION Chapter 2 Disease and disease transmission An enormous variety of organisms exist, including some which can survive and even develop in the body of people or animals. If the organism can cause infection, it is an infectious agent. In this manual infectious agents which cause infection and illness are called pathogens. Diseases caused by pathogens, or the toxins they produce, are communicable or infectious diseases (45). In this manual these will be called disease and infection. This chapter presents the transmission cycle of disease with its different elements, and categorises the different infections related to WES. 2.1 Introduction to the transmission cycle of disease To be able to persist or live on, pathogens must be able to leave an infected host, survive transmission in the environment, enter a susceptible person or animal, and develop and/or multiply in the newly infected host. The transmission of pathogens from current to future host follows a repeating cycle. This cycle can be simple, with a direct transmission from current to future host, or complex, where transmission occurs through (multiple) intermediate hosts or vectors. This cycle is called the transmission cycle of disease, or transmission cycle. The transmission cycle has different elements: The pathogen: the organism causing the infection The host: the infected person or animal ‘carrying’ the pathogen The exit: the method the pathogen uses to leave the body of the host Transmission: how the pathogen is transferred from host to susceptible person or animal, which can include developmental stages in the environment, in intermediate hosts, or in vectors 7 CONTROLLING AND PREVENTING DISEASE The environment: the environment in which transmission of the pathogen takes place. -
Global Climate Coalition Primer on Climate Change Science
~ ~ Chairman F.SOHWAB Poraohe TECH-96-29 1st Viae C".lrrn.n C. MAZZA 1/18/96 Hyundal 2nd Vic. Ohalrrnan C. SMITH Toyota P S_cret.ry C. HELFMAN TO: AIAM Technical Committee BMW Treasurer .,J.AMESTOY Mazda FROM: Gregory J. Dana Vice President and Technical Director BMW c ••woo Flat RE: GLOBAL CLIMATE COALITION-(GCC)· Primer on Honda Hyundal Climate Change Science· Final Draft lauzu Kia , Land Rover Enclosed is a primer on global climate change science developed by the Mazda Mlt8ublehl GCC. If any members have any comments on this or other GCC NIB.an documents that are mailed out, please provide me with your comments to Peugeot forward to the GCC. Poreche Renault RolI&-Aoyoe S ••b GJD:ljf ""al'"u .z.ukl Toyota VOlkswagen Volvo President P. HUTOHINSON ASSOCIATION OF INTERNATIONAL AUTOMOBILE MANUFACTURERS. INC. 1001 19TH ST. NORTH. SUITE 1200 • ARLINGTON, VA 22209. TELEPHONE 703.525.7788. FAX 703.525.8817 AIAM-050771 Mobil Oil Corporation ENVIRONMENTAL HEALTH AND SAFETY DEPARTh4ENT P.O. BOX1031 PRINCETON, NEW JERSEY 08543-1031 December 21, 1995 'To; Members ofGCC-STAC Attached is what I hope is the final draft ofthe primer onglobal climate change science we have been working on for the past few months. It has been revised to more directly address recent statements from IPCC Working Group I and to reflect comments from John Kinsman and Howard Feldman. We will be discussing this draft at the January 18th STAC meeting. Ifyou are coming to that meeting, please bring any additional comments on the draft with you. Ifyou have comments but are unable to attend the meeting, please fax them to Eric Holdsworth at the GeC office. -
Data–Model Fusion to Better Understand Emerging Pathogens and Improve Infectious Disease Forecasting
July 2011 DATA ASSIMILATION FOR ECOLOGICAL FORECASTING Ecological Applications, 21(5), 2011, pp. 1443–1460 Ó 2011 by the Ecological Society of America Data–model fusion to better understand emerging pathogens and improve infectious disease forecasting 1,5 2 3 4 1 SHANNON L. LADEAU, GREGORY E. GLASS, N. THOMPSON HOBBS, ANDREW LATIMER, AND RICHARD S. OSTFELD 1Cary Institute of Ecosystem Studies, Millbrook, New York 12545 USA 2Johns Hopkins School of Public Health, Department of Molecular Microbiology and Immunology, Baltimore, Maryland 21205 USA 3Colorado State University, Natural Resource Ecology Laboratory and Graduate Degree Program in Ecology, Fort Collins, Colorado 80524 USA 4University of California, Department of Plant Sciences, Davis, California 95616 USA Abstract. Ecologists worldwide are challenged to contribute solutions to urgent and pressing environmental problems by forecasting how populations, communities, and ecosystems will respond to global change. Rising to this challenge requires organizing ecological information derived from diverse sources and formally assimilating data with models of ecological processes. The study of infectious disease has depended on strategies for integrating patterns of observed disease incidence with mechanistic process models since John Snow first mapped cholera cases around a London water pump in 1854. Still, zoonotic and vector-borne diseases increasingly affect human populations, and methods used to successfully characterize directly transmitted diseases are often insufficient. We use four case studies to demonstrate that advances in disease forecasting require better understanding of zoonotic host and vector populations, as well of the dynamics that facilitate pathogen amplification and disease spillover into humans. In each case study, this goal is complicated by limited data, spatiotemporal variability in pathogen transmission and impact, and often, insufficient biological understanding. -
Adenoviral Vector COVID-19 Vaccines: Process and Cost Analysis
processes Article Adenoviral Vector COVID-19 Vaccines: Process and Cost Analysis Rafael G. Ferreira 1,* , Neal F. Gordon 2, Rick Stock 2 and Demetri Petrides 3 1 Intelligen Brasil, Sao Paulo 01227-200, Brazil 2 BDO USA, LLP, Boston, MA 02110, USA; [email protected] (N.F.G.); [email protected] (R.S.) 3 Intelligen, Inc., Scotch Plains, NJ 07076, USA; [email protected] * Correspondence: [email protected] Abstract: The COVID-19 pandemic has motivated the rapid development of numerous vaccines that have proven effective against SARS-CoV-2. Several of these successful vaccines are based on the adenoviral vector platform. The mass manufacturing of these vaccines poses great challenges, especially in the context of a pandemic where extremely large quantities must be produced quickly at an affordable cost. In this work, two baseline processes for the production of a COVID-19 adenoviral vector vaccine, B1 and P1, were designed, simulated and economically evaluated with the aid of the software SuperPro Designer. B1 used a batch cell culture viral production step, with a viral titer of 5 × 1010 viral particles (VP)/mL in both stainless-steel and disposable equipment. P1 used a perfusion cell culture viral production step, with a viral titer of 1 × 1012 VP/mL in exclusively disposable equipment. Both processes were sized to produce 400 M/yr vaccine doses. P1 led to a smaller cost per dose than B1 ($0.15 vs. $0.23) and required a much smaller capital investment ($126 M vs. $299 M). The media and facility-dependent expenses were found to be the main contributors to the operating cost. -
STD (Sexually Transmitted Disease) Or STI (Sexually Transmitted Infection): Should We Choose? Janet Byron Anderson, Phd
STD (sexually transmitted disease) or STI (sexually transmitted infection): Should we choose? Janet Byron Anderson, PhD 1. Clinical foundation of the problem Another surprise: Documented incidence had shown Each of the terms—“sexual(ly)”, “transmitted”, “disease”, that the two routes of sexual transmission were male-to- and “infection”—is problematic independently, as this female and male-to-male. However, on 15 July 2016 the study will show. Moreover, co-occurring variants, used CDC reported the first case of suspected female-to-male as synonyms in English medical articles worldwide, ag- sexual transmission in New York City [4]. Since 2008, gravate the problem. The purpose of this study is to pro- then, the Zika virus has shown that it is now sexually pose a single term that can stimulate discussion about transmissible. “Transmissible” denotes a potential, and is whether the co-occurring variants are clinically and lin- distinct from “transmitted”, which denotes a reality. guistically justifiable—especially now, when STDs/STIs To say that Zika has proved to be transmissible through have become a global health problem, and public health sexual contact means that it can be transmitted through agencies in every country are scrambling to educate their sex but that it need not be (Zika remains a chiefly vec- citizens. [Until the presentation advances to the point tor-borne disease). However, cases reported since 2008 where the question posed in the title can be definitively document the reality of transmittedness through sexual answered, I’ll use the expression “STD/STI” or the terms contact. “illness(es)” and “condition(s)”.] The predisposing epidemiologic context will first be clar- This carefully differentiated language is used by the ified, for it sheds light on two of the problematic terms: European Centre for Disease Prevention and Control chiefly “transmitted” but also “sexual(ly)”.